United Arab Emirates
8 Vaccines Approved for Use in United Arab Emirates
Protein Subunit
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)
Approved in 1 country
3 trials in 2 countries
Approval Source: scmp.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: u.ae
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: nature.com
Inactivated
9 in Clinical Trials in United Arab Emirates
Protein Subunit
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)
Approved in 1 country
3 trials in 2 countries
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
Protein Subunit
Sinocelltech
SCTV01C
12 trials in 2 countries
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
25 trials in 8 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Protein Subunit
Jiangsu Rec-Biotechnology Co Ltd
ReCOV
6 trials in 3 countries
RNA
Suzhou Abogen Biosciences
ABO1009-DP
2 trials in 2 countries